ArchivePrimary membranous nephropathy (PMN) [or idiopathic membranous nephropathy (IMN)] belongs to one of the most common pathological type of membranous glomerular nephropathy. As the development of anti-phospholipase A2 receptor antibody and anti-thrombospondin type-1 domain-containing 7A antibody for IMN treatment, the new immune-suppressants such as tacrolimus, and monoclonal antibodies such as rituximab have been successively used in IMN treatment. This review describes the recent progress in IMN diagnosis and its treatment.
IgA nephropathy is the most common primary glomerulonephritis. Renal biopsy remains the definitive diagnostic method of IgA nephropathy. Recently, the development of new diagnostic markers and therapeutic drugs provide some new ideas for the diagnosis and treatment of IgA nephropathy. There is still a lack of specific immunosuppressive therapy. This review describes the progress of IgA nephropathy diagnosis and its treatment.
During pregnancy period, the body system of pregnant women has some special adaptive changes including in kidney. However, some pathological changes in kidney may cause diseases. The common pregnancy-related renal injury includes gestational hypertension related renal injury, acute renal injury during pregnancy, and gestational special renal injury. As long as the chronic kidney disease (CKD) combines with pregnancy, the CKD patient's condition might be aggravated and even renal failure. This review describes renal physiology characteristics, common pregnancy-ralated renal injury and CKD combined with pregnancy, to improve the clinical treatment of gestational common renal injury.
Diabetic nephropathy is one of the most common complications of diabetes, which is a serious chronic disease to threaten human life and health. If without good treatment it may develop to the end stage renal disease (ESRD) and require renal replacement therapy. Based on domestic and foreign literature in recent years, this review describes the diabetic nephropathy diagnosis and its treatment.
Intradialytic hypotension (IDH) is one of the most common complications during hemodialysis, which is an independent risk factor of death in dialysis patients. The prevention and treatment of IDH are clinically important to improve the life quality and survival rate of hemodialysis patients. This review summarizes recent progress of the prevention and management of IDH.
Tunneled cuff catheters (TCC) have been commonly used in dialysis patients. However, this process use may cause the removal obstacles of central venous catheter due to variety of reasons, among them, stuck catheter and adhesion have been paid more attention. Stuck catheter means adhesion of the catheter to the central venous when the cuff of the TCC is separated, which may lead to removal obstacles. This stuck catheter might be due to the formation of fibrin sheath and the later calcification, which can result in more severe catheter incarceration. Usually, the TCC used over two years, or the patient with central venous stenosis may significantly increase the incidence rate of removal obstacles. This review describes common risk factors of stuck catheter, and the countermeasures for the removal obstacles of central venous catheter.
To evaluate the efficacy and safety of intravenous thrombolysis in the patients who suffered from acute ischemic stroke with unruptured cerebral aneurysms.
The clinical data of 275 acute ischemic stroke patients admitted in Changhai Hospital from September 2013 to May 2016, who received intravenous thrombolysis, were analyzed retrospectively. The 275 patients were divided into aneurysm group (n = 24) and non aneurysm group (n = 251) through CTA/MRA. The curative effect, prognosis and intracranial hemorrhage were compared between the two groups.
There was no significant difference in demographic characteristics and past medical history between two groups. There was no significant difference in efficacy and prognosis between two groups. There was no statistical difference in the intracranial hemorrhage between two groups (P>0.05).
Intravenous thrombolysis is effective and safe in patients with acute ischemic stroke accompanied by unruptured cerebral aneurysms.
To evaluate the clinical efficacy and safety of Bailing tablet in the treatment of vitiligo.
Randomized controlled trials (RCTs) for the vitiligo treatment using Bailing tablet were retrieved, and the retrieval data were due on September 5, 2017. The Meta-analysis was performed by using RevMan 5.2 software after data extraction, and the quality of the included researches were evaluated according to the Cochrane 5.0.2 manual requirements. The outcome indicators were expressed in relative risk (RR), 95% confidence interval (CI) and P values.
Total 17 RCTs were enrolled. The quality of the included researches were low. The results of data analysis showed that the total effective rate of experiment group [Bailing tablet combined with traditional Chinese medicine or narrow spectrum medium wave ultraviolet (NB-UVB)] was significantly better than that of control group (traditional Chinese medicine or NB-UVB)[RR=1.33, 95% CI (1.07, 1.67), P=0.01]. Because of the different interventions of control group, we conducted subgroup analysis on the same interventions. However, the subgroup Meta analysis results showed that the total effective rate of using Bailing tablet alone in the treatment of vitiligo was markedly lower than the Chinese traditional medicine group, the NB-UVB group and the combination group of Bailing tablet or the traditional Chinese medicine and western medicine ointment [RR=0.65, 95%CI (0.57, 0.75),P<0.000 01]. The corresponding outcome indicators respectively were [RR=0.63, 95%CI (0.51, 0.79),P < 0.000 01], [RR=0.72, 95% CI (0.61, 0.84), P < 0.000 1] and [RR=0.63, 95% CI (0.51, 0.78), P < 0.000 1).
Bailing tablet has certain therapeutic effect on vitiligo treatment and no serious adverse reactions. However, Bailing tablet should be used as combination with other treatments.
To explore the anti-aging effect of Yiling wine on model of D-galactose-induced aging mice.
The other groups except the control group were establish the model of D-galactose-induced aging mice, all mice were randomly divided into control group, model group, vitamin E group, 2% and 5% each dose Yiling wine group. Obseving and collecting mice serum samples for biochemical indicators of superoxide dismutase (SOD), malondialdehyde (MDA), catalase (CAT), and total antioxidant capacity (T-AOC). Meanwhile, the effect of improving learning and memory abilities were investigated through the Morris water maze test.
In Morris water maze test, there was no significant difference in swimming distance of the mice in each group (P>0.05). But compared with the control group, times that mice across the platform of model group were decreased, different doses of 2% Yiling wine and vitamin E groups increased the frequency of crossing the original platform, but there were no significant differences (P>0.05); Compared with the model group, spleen index in vitamin E group, 2% and 5% high dose Yiling wine groups were higher, the differences were statistical significance (P<0.01). Compared with the control group, model group decreased the levels of serum CAT and T-AOC but increased MDA level (P<0.05 or P<0.01); After intragastric administration of Yiling wine, compared with model group, the levels of serum MDA were decreased in 2% high dose Yiling wine group and 5% Yiling wine in each dose group, the level of serum T-AOC was increased in 2% high dose Yiling wine group, the levels of serum SOD and CAT were increased in 2% and 5% Yiling wine in each dose group, and the differences were statistically significant (P<0.05 or P<0.01).
Yiling wine can improve the antioxidant capacity and immunity in D-galactose-induced aging mice, it can also improve their antioxidant capacity and immunity, it has a certain effect on retarding aging.
To study the inhibitory effect of HY152-J against artificial restructured human liver microsomal CYP450 enzymes in vitro.
The method of single substrate CYP450 enzyme probe was used to study the inhibitory effect of HY152-J, and the metabolites of the precipitated samples for each probe were analyzed by LC-MS/MS. The concentration of metabolites was assayed to calculate the IC50 for inhibitory potency evaluation.
The residual activities of CYP3A4 (6β-hydroxytestosterone), CYP3A4 (1-hydroxymidazolam), CYP2C19 (4-hydroxymephenytoin), CYP2D6 (dextrophan), CYP1A2 (acetaminophen) and CYP2C9 (4-hydroxydiclofenac) were analyzed as 4.6%, 0.6%, 0.3%, 8.1%, 32.5% and 15.3% respectively, and the IC50 values were 21.02, 2.66, 1.23,14.9, 71.0 and 35.8 μmol/L.
The inhibitory effects of HY152-J on CYP3A4 (1-hydroxymidazolam), CYP2C19 are moderate inhibition,and the effects on CYP3A4 (6β-hydroxytestosterone), CYP2D6, CYP1A2 and CYP2C9 are very few effections.
Valproate is widely used in the treatment of epilepsy. Recently, the pharmacogenetics studies have showed that some genes could affect the pharmacokinetics of valproate. This review describes the pharmacogenomics of valproate and its research directions.
Vitiligo is a common skin depigmentation disease without effective treatment. Currently, the major treatments include drug treatment, phototherapy, bleaching, covering therapy and surgical treatment. This review describes commonly used drug therapies for vitiligo and the new drug research progress for vitiligo.
Multiple myeloma (MM) is a common malignant blood tumor. Meantime, there is still no cure method and its recurrence rate is very high. Panobinostat is a histone deacetylase inhibitor (HDACi), which is used in MM treatment. This review summarizes the panobinostat used in MM treatment including its action mechanism against HDACi and its adverse reactions.